Obana Y, Murakami T, Kuzui H, Nishino T
Department of Microbiology, Kyoto Pharmaceutical University.
Jpn J Antibiot. 1990 Dec;43(12):2094-101.
In vitro interactions between carumonam (CRMN) and 8 other antibiotics were studied using the agar dilution checkerboard technique against 88 clinical isolates of Escherichia coli, Proteus vulgaris, Serratia marcescens and Pseudomonas aeruginosa. Combinations of CRMN with 8 other antibiotics were generally additive or indifferent. Synergism was found against S. marcescens or P. aeruginosa with CRMN plus fosfomycin, gentamicin (GM) or dibekacin. Antagonism was not observed with CRMN plus any of the 8 other antibiotics tested. In a phase-contrast microscopic study, the synergism of CRMN in combination with GM were confirmed against P. aeruginosa 15846. CRMN in combination with GM demonstrated a in vivo synergy against experimental urinary tract infection caused by P. aeruginosa 15846 in mice. We think that combinations of several antibiotics with CRMN should be appropriate for initial therapy of infections because no antagonism appeared to occur with other antibiotic agents.
采用琼脂稀释棋盘法,针对88株临床分离的大肠杆菌、普通变形杆菌、粘质沙雷氏菌和铜绿假单胞菌,研究了卡芦莫南(CRMN)与其他8种抗生素之间的体外相互作用。CRMN与其他8种抗生素的组合通常为相加作用或无相互作用。发现CRMN联合磷霉素、庆大霉素(GM)或地贝卡星对粘质沙雷氏菌或铜绿假单胞菌有协同作用。CRMN与所测试的其他8种抗生素中的任何一种联合使用均未观察到拮抗作用。在相差显微镜研究中,证实了CRMN与GM联合对铜绿假单胞菌15846具有协同作用。CRMN与GM联合对小鼠实验性铜绿假单胞菌15846引起的尿路感染具有体内协同作用。我们认为,几种抗生素与CRMN联合应用应适合感染的初始治疗,因为与其他抗生素联合似乎不会产生拮抗作用。